Aqueous ophthalmic composition

Patent metadata

Field	Value
Publication number	US-2017105934-A1
Application number	US-201515317851-A
Country	US
Kind code	A1
Filing date	Jun 9, 2015
Priority date	Jun 10, 2014
Publication date	Apr 20, 2017
Grant date	—

Abstract

An aqueous ophthalmic composition is provided comprising at least one component which is selected from the group consisting of a polysaccharide, a monosaccharide, at least one vitamin component selected from the group consisting of vitamin B12, vitamin B2, vitamin A and panthenol, at least one oil component selected from the group consisting of a plant oil, an animal oil and a mineral oil, at least one surfactant selected from the group consisting of polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene glycol and polyoxyl stearate, an anti-allergic component, a preservative, a thickening component, a polyhydric alcohol, an anti-inflammatory component, an anti-bacterial agent and a cooling and/or refreshing agent; and (B) a buffering agent. When the composition is brought into contact with a polybutylene terephthalate-containing resin container, the container can be prevented from weight change, deterioration and wetting and can be improved in a liquid cutting property.

First claim

1 . An aqueous ophthalmic composition, comprising
(A) at least one surfactant selected from the group consisting of polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene glycol, polyoxyl stearate, and polysorbate 80; at least one cooling and/or refreshing agent of 0.015-0.1 w/v % selected from the group consisting of eucalyptus oil and bergamot oil, and menthol; and (B) a buffering agent; wherein (C) the aqueous ophthalmic composition is held in a container in which a part of a surface or the whole surface that is brought into contact with the aqueous ophthalmic composition is molded with a resin containing polybutylene terephthalate.

2 . The aqueous ophthalmic composition according to claim 1 , further comprising at least one polyhydric alcohol selected from the group consisting of propylene glycol, glycerin, polyethylene glycol, and mannitol.

3 . The aqueous ophthalmic composition according to claim 1 , further comprising chlorobutanol.

4 - 6 . (canceled)

7 . The aqueous ophthalmic composition according to claim 1 , further comprising at least one thickening component selected from the group consisting of carboxymethyl cellulose, methyl cellulose, hydroxyethyl cellulose, vinyl-based polymer compound, and salts thereof.

8 . The aqueous ophthalmic composition according to claim 1 , further comprising at least one decongestants selected from the group consisting of tetrahydrozoline hydrochloride, naphazoline hydrochloride, naphazoline nitrate, epinephrine, epinephrine hydrochloride, ephedrine hydrochloride, phenylephrine hydrochloride, and methylephedrine hydrochloride.

9 . A method for imparting a function of inhibiting change in weight of a polybutylene terephthalate-containing resin container to an aqueous composition by allowing
(A) at least one surfactant selected from the group consisting of polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene glycol, polyoxyl stearate, and polysorbate 80; at least one cooling and/or refreshing agent of 0.015-0.1 w/v % selected from the group consisting of eucalyptus oil, bergamot oil, and menthol; and (B) a buffering agent;
to coexist in the aqueous composition.

10 . The method according to claim 9 , wherein said aqueous composition further comprising at least one polyhydric alcohol selected from the group consisting of propylene glycol, glycerin, polyethylene glycol, and mannitol.

11 . The method according to claim 9 , wherein said aqueous composition further comprising chlorobutanol.

12 . The method according to claim 9 , wherein said aqueous composition further comprising at least one thickening component selected from the group consisting of carboxymethyl cellulose, methyl cellulose, hydroxyethyl cellulose, vinyl-based polymer compound, and salts thereof.

13 . The method according to claim 9 , wherein said aqueous composition further comprising at least one decongestants selected from the group consisting of tetrahydrozoline hydrochloride, naphazoline hydrochloride, naphazoline nitrate, epinephrine, epinephrine hydrochloride, ephedrine hydrochloride, phenylephrine hydrochloride, and methylephedrine hydrochloride.

14 . A method for imparting a function of inhibiting wetting of a polybutylene terephthalate-containing resin container to an aqueous composition by allowing
(A) at least one surfactant selected from the group consisting of polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene glycol, polyoxyl stearate, and polysorbate 80; at least one cooling and/or refreshing agent of 0.015-0.1 w/v % selected from the group consisting of eucalyptus oil, bergamot oil, and menthol; and (B) a buffering agent;
to coexist in the aqueous composition.

15 . The method according to claim 14 , wherein said aqueous composition further comprising at least one polyhydric alcohol selected from the group consisting of propylene glycol, glycerin, polyethylene glycol, and mannitol.

16 . The method according to claim 14 , wherein said aqueous composition further comprising chlorobutanol.

17 . The method according to claim 14 , wherein said aqueous composition further comprising at least one thickening component selected from the group consisting of carboxymethyl cellulose, methyl cellulose, hydroxyethyl cellulose, vinyl-based polymer compound, and salts thereof.

18 . The method according to claim 14 , wherein said aqueous composition further comprising at least one decongestants selected from the group consisting of tetrahydrozoline hydrochloride, naphazoline hydrochloride, naphazoline nitrate, epinephrine, epinephrine hydrochloride, ephedrine hydrochloride, phenylephrine hydrochloride, and methylephedrine hydrochloride.

Assignees

• Rohto Pharma

Inventors

• Mizutare Yoko
• Matsumura Yasuko

Classifications

• A61K47/18

  Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids · CPC title

• A61K47/12

  Carboxylic acids; Salts or anhydrides thereof · CPC title

• A61P27/14

  Decongestants or antiallergics · CPC title

• A61K9/0048 Primary

  Eye, e.g. artificial tears · CPC title

• A61P27/02

  Ophthalmic agents · CPC title